metformin has been researched along with Teratogenesis in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Teratogenesis: The formation of CONGENITAL ABNORMALITIES.
Excerpt | Relevance | Reference |
---|---|---|
"Metformin has been prescribed in pregnancy for over 40 years; for much of this time, use has been limited both in numbers and geographically, and the evidence base has been confined to observational studies." | 8.95 | Metformin use in pregnancy: promises and uncertainties. ( Lindsay, RS; Loeken, MR, 2017) |
"Metformin has been prescribed in pregnancy for over 40 years; for much of this time, use has been limited both in numbers and geographically, and the evidence base has been confined to observational studies." | 4.95 | Metformin use in pregnancy: promises and uncertainties. ( Lindsay, RS; Loeken, MR, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lindsay, RS | 1 |
Loeken, MR | 1 |
1 review available for metformin and Teratogenesis
Article | Year |
---|---|
Metformin use in pregnancy: promises and uncertainties.
Topics: Female; Humans; Hypoglycemic Agents; Metformin; Pregnancy; Teratogenesis | 2017 |